262 related articles for article (PubMed ID: 17327657)
1. EUCLID: an outcome analysis tool for high-dimensional clinical studies.
Gayou O; Parda DS; Miften M
Phys Med Biol; 2007 Mar; 52(6):1705-19. PubMed ID: 17327657
[TBL] [Abstract][Full Text] [Related]
2. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
3. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships.
El Naqa I; Suneja G; Lindsay PE; Hope AJ; Alaly JR; Vicic M; Bradley JD; Apte A; Deasy JO
Phys Med Biol; 2006 Nov; 51(22):5719-35. PubMed ID: 17068361
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison between 3DCRT and IMRT using different multileaf collimators in the treatment of brain tumors.
Ding M; Newman F; Chen C; Stuhr K; Gaspar LE
Med Dosim; 2009; 34(1):1-8. PubMed ID: 19181248
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
6. Intensity modulated radiation therapy versus three dimensional conformal radiation therapy for treatment of high grade glioma: a radiobiological modeling study.
De La Fuente Herman T; Ahmad And S; Vlachaki MT
J Xray Sci Technol; 2010; 18(4):393-402. PubMed ID: 21045276
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the influence of setup uncertainties on treatment planning for focal liver tumors.
Balter JM; Brock KK; Lam KL; Tatro D; Dawson LA; McShan DL; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):610-4. PubMed ID: 16095848
[TBL] [Abstract][Full Text] [Related]
9. On the visualization of universal degeneracy in the IMRT problem.
Alber ML; Meedt G
Radiat Oncol; 2006 Dec; 1():47. PubMed ID: 17176462
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
[TBL] [Abstract][Full Text] [Related]
11. IMRT treatment planning based on prioritizing prescription goals.
Wilkens JJ; Alaly JR; Zakarian K; Thorstad WL; Deasy JO
Phys Med Biol; 2007 Mar; 52(6):1675-92. PubMed ID: 17327656
[TBL] [Abstract][Full Text] [Related]
12. Clinical implementation of tangential field intensity modulated radiation therapy (IMRT) using sliding window technique and dosimetric comparison with 3D conformal therapy (3DCRT) in breast cancer.
Selvaraj RN; Beriwal S; Pourarian RJ; Lalonde RJ; Chen A; Mehta K; Brunner G; Wagner KA; Yue NJ; Huq SM; Heron DE
Med Dosim; 2007; 32(4):299-304. PubMed ID: 17980832
[TBL] [Abstract][Full Text] [Related]
13. Normal tissue complication probability modelling of tissue fibrosis following breast radiotherapy.
Alexander MA; Brooks WA; Blake SW
Phys Med Biol; 2007 Apr; 52(7):1831-43. PubMed ID: 17374914
[TBL] [Abstract][Full Text] [Related]
14. Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients.
St-Hilaire J; Sévigny C; Beaulieu F; Germain F; Lavoie C; Dagnault A; Gingras L; Tremblay D; Beaulieu L
Radiother Oncol; 2009 Jun; 91(3):342-8. PubMed ID: 19135749
[TBL] [Abstract][Full Text] [Related]
15. Optimum parameters in a model for tumour control probability, including interpatient heterogeneity: evaluation of the log-normal distribution.
Keall PJ; Webb S
Phys Med Biol; 2007 Jan; 52(1):291-302. PubMed ID: 17183142
[TBL] [Abstract][Full Text] [Related]
16. Patient-specific IMRT verification using independent fluence-based dose calculation software: experimental benchmarking and initial clinical experience.
Georg D; Stock M; Kroupa B; Olofsson J; Nyholm T; Ahnesjö A; Karlsson M
Phys Med Biol; 2007 Aug; 52(16):4981-92. PubMed ID: 17671348
[TBL] [Abstract][Full Text] [Related]
17. Normal tissue complication probability: does simultaneous integrated boost intensity-modulated radiotherapy score over other techniques in treatment of prostate adenocarcinoma.
Basu KS; Bahl A; Subramani V; Sharma DN; Rath GK; Julka PK
J Cancer Res Ther; 2009; 5(2):78-84. PubMed ID: 19542662
[TBL] [Abstract][Full Text] [Related]
18. Speed optimized influence matrix processing in inverse treatment planning tools.
Ziegenhein P; Wilkens JJ; Nill S; Ludwig T; Oelfke U
Phys Med Biol; 2008 May; 53(9):N157-64. PubMed ID: 18401066
[TBL] [Abstract][Full Text] [Related]
19. Stochastic versus deterministic kernel-based superposition approaches for dose calculation of intensity-modulated arcs.
Tang G; Earl MA; Luan S; Wang C; Cao D; Yu CX; Naqvi SA
Phys Med Biol; 2008 Sep; 53(17):4733-46. PubMed ID: 18701770
[TBL] [Abstract][Full Text] [Related]
20. Probability dynamics of a repopulating tumor in case of fractionated external radiotherapy.
Stavreva N; Stavrev P; Fallone BG
Phys Med; 2009 Dec; 25(4):181-91. PubMed ID: 19345599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]